Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f21c1009c60308a64b8e7dc0bb989632 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2012-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_665b618d9fe82b1314331159e5bbbfd8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41b2a917644e7647d953222d7c8c6b57 |
publicationDate |
2017-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2600081-T3 |
titleOfInvention |
Use of sulfated glycosaminoglycans to improve the bioavailability of Factor VIII |
abstract |
Factor VIII for use in the treatment or prevention of a bleeding disorder, said treatment or prevention comprising non-intravenous injection of said Factor VIII together with a sulfated glycosaminoglycan, in which Factor VIII is administered subcutaneously at a dose of 50 IU / kg body weight at about 1,000 IU / kg body weight, and in which the amount of sulfated glycosaminoglycan is between 0.001 and 100 mg per mL of product applied. |
priorityDate |
2011-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |